IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- IOL Chemicals and Pharmaceuticals Ltd reported highest ever revenue in Q3/9 Months' FY2010-02-2020
10-02-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Statement Of Deviation Or Variation For Proceeds Of Warrants Issued On Preferential Basis On March 2019.
With reference to the captioned subject and pursuant to Regulations 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular No.: CIR/CFD/CMDl/162/2019 dated 24.12.2019, please find enclosed herewith Statement of Deviation or Variation for proceeds of warrants issued on preferential basis on March 2019. The aforesaid statement has also been reviewed by the Audit and Risk Management Committee in its meeting held on 10.02.2020. This is for your information & record.10-02-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Outcome Of The Board Meeting Dated 10 February 2020
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 10th February, 2020 has interalia considered and approved the Audited Financial Results for the Quarter and Nine Months ended 31 December 2019.10-02-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Financial Results For The Quarter And Nine Months Ended 31 December 2019
Audited Financial Results for the Quarter and Nine Months ended 31 December 2019.10-02-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in Newspapers04-02-2020
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2019
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2020 ,inter alia, to consider and approve financial results of the Company for the quarter and nine months ended 31 December 201903-02-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Clarification
With reference to Movement in Volume, IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of Clarification is enclosed.28-01-2020
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Clarification sought from IOL Chemicals & Pharmaceuticals Ltd
The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on January 28, 2020, with reference to Movement in Volume.The reply is awaited.28-01-2020
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Shareholding for the Period Ended December 31, 2019
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here17-01-2020
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates13-01-2020